Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B

Otros/as autores/as

Institut Català de la Salut

[Buti M, Riveiro-Barciela M, Roade L, Esteban R] Unitat del Fetge, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Stepanova M, Nader F] Center for Outcomes Research in Liver Disease, Washington, DC, USA. [Palom A] Unitat del Fetge, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Younossi Z] Department of Medicine, Center for Liver Diseases, Inova Fairfax, Hospital, Falls Church, VA, USA. Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA

Vall d'Hebron Barcelona Hospital Campus

Fecha de publicación

2022-01-13T14:14:48Z

2022-01-13T14:14:48Z

2021-06



Resumen

Hepatitis vírica; Qualitat de vida relacionada amb la salut; Malaltia hepàtica crònica


Hepatitis viral; Calidad de vida relacionada con la salud; Enfermedad crónica del hígado


Viral hepatitis; Health-related quality of life; Chronic Liver Disease


Background & Aims Health-related quality of life (HRQoL) determined by patient-reported outcomes (PROs) is impaired in chronic hepatitis B (CHB) and C patients, but there are no data regarding patients with chronic hepatitis D (CHD). The aim of this study was to assess PRO scores in untreated patients with CHD and compare them with those obtained for patients with CHB. Methods Patients with CHD completed 3 PRO instruments (Chronic Liver Disease Questionnaire [CLDQ], Functional Assessment of Chronic Illness Therapy–Fatigue [FACIT-F], and Work Productivity and Activity Impairment [WPAI]), and the results were compared with those of patients mono-infected with CHB. Results In total, 125 patients were included: 43 with CHD and 82 with CHB. Overall, baseline PROs showed differences between both groups. Several assessments, such as the worry score from CLDQ (p = 0.0118), functional well-being from FACIT-F (p = 0.0281), and activity impairment from WPAI (p = 0.0029) showed a significant trend to worse scores in patients with CHD than with CHB. In addition, the linear regression model supports the finding that having CHD as opposed to having CHB was a predictor of a higher worry score (CLDQ) and a higher activity impairment (WPAI). Conclusions In this first assessment in CHD, PROs recorded in patients with CHD showed a significant impairment in some domains of HRQoL questionnaires in comparison with those with CHB. Studies in larger cohorts with lengthier follow-up are needed to fully assess patient-reported quality of life over the course of CHD. Lay summary Chronic hepatitis D (CHD) is a viral disease that causes rapid evolution to liver cirrhosis, amongst other severe complications, when compared to patients with chronic hepatitis B (CHB). Health-related quality of life in chronic hepatitis C and CHB has been reported widely, but no studies have been performed on patient-reported outcomes in patients with CHD. Results showed that CHD patients reported worse outcomes in psychological domains such as worry and emotional well-being, as well as in physical domains such as abdominal symptoms, physical well-being, and activity impairment in comparison with patients with CHB.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

Elsevier

Documentos relacionados

JHEP reports;3

https://doi.org/10.1016/j.jhepr.2021.100280

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)